Moteur de recherche d’entreprises européennes

Financement de l’UE (5 884 310 €) : La recherche sur les maladies rares d’ERA-NET met en œuvre les objectifs de l’IRDiRC Hor 01/12/2014 Programme de recherche et d'innovation de l'UE « Horizon »

Vue d’ensemble

Texte

La recherche sur les maladies rares d’ERA-NET met en œuvre les objectifs de l’IRDiRC

Rare diseases (RD) are diseases that affect not more than 5 per 10 000 persons (according to the EU definition). 7000 distinct rare diseases exist, affecting between 6% and 8% of the population (about 30 million EU citizens). The lack of specific health policies for rare diseases and the scarcity of the expertise, translate into delayed diagnosis, few medicinal products and difficult access to care. That is why rare diseases are a prime example of a research area that strongly profits from coordination on a European scale. At present only few European countries fund research on rare diseases through specific dedicated programmes. Therefore, the funding of transnational collaborative research is the most effective joint activity to enhance the cooperation between scientists working on rare diseases in Europe and beyond. The E-Rare consortium was built to link responsible funding bodies that combine the scarce resources and fund rare disease research via Joint Transnational Calls (JTCs). The current E-Rare-3 project proposal will extend and strengthen the transnational cooperation by building on the experience and results of the previous E-Rare-1&2 programmes. The consortium comprises 26 institutions from 17 European, Associated and non-European countries. Its international dimension will be directly translated into close collaboration with IRDiRC and other relevant European and international initiatives. IRDiRC guidelines and policies will be implemented in the four JTCs and representatives of the IRDiRC Scientific Committees will be invited to join the Advisory Board of E-Rare-3. Members of the EUCERD group will be involved in identifying rare disease research needs. Patients’ organizations from Europe (represented by EURORDIS) and beyond will be invited as a key partner towards collaborative efforts for research promotion and funding. The collaboration with European Research Infrastructures will be consolidated to enhance efficient and participative research.


Agence Nationale de la Recherche 710 253 €
Bundesministerium Fuer Forschung Technologie UND Raumfahrt 1 035 870 €
Canadian Institutes OF Health Research 0,00 €
Deutsche Forschungsgemeinschaft e. V. 384 635 €
Deutsches Zentrum FUR Luft - UND Raumfahrt e. V. 59 018 €
Fonds de la Recherche Scientifique- FNRS 137 166 €
Fonds DE Recherche Du Quebec - Sante 0,00 €
Fonds Voor Wetenschappelijk Onderzoek-Vlaanderen 124 142 €
Fonds ZUR Förderung DER Wissenschaftlichen Forschung 303 231 €
Fundacao para A Ciencia e A Tecnologia 164 844 €
Geniki Grammatia Erevnas Kai Kainotomias 150 597 €
Genome Canada 0,00 €
Instituto de Salud Carlos III 221 827 €
Istituto Superiore Di Sanita 59 018 €
Latvijas Zinatnu Akademija 0,00 €
Ministero Della Salute 384 635 €
Ministry OF Health 137 166 €
Narodowe Centrum Badan i Rozwoju 221 827 €
Nemzeti Kutatasi Fejlesztesi ES Innovacios Hivatal 107 861 €
Osterreichische Forschungsforderungsgesellschaft mbH 0,00 €
Regione Emilia Romagna 303 231 €
Schweizerischer Nationalfonds ZUR Forderung DER Wissenschaftlichen Forschung 0,00 €
Turkiye Bilimsel VE Teknolojik Arastirma Kurumu 384 635 €
Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii 221 827 €
Valsts Izglitibas Attistibas Agentura 127 398 €
Zorgonderzoek Nederland ZON 645 129 €

https://cordis.europa.eu/project/id/643578

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.